NCT06645691 2024-12-06
POLARIC-13
National Heart Centre Singapore
Phase 2 Recruiting
Clinical Trials
6 trialsNCT04258683 2023-08-29
A Study of Pembrolizumab Added to the Standard First-Line Therapy of Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) for NDMM NTE
Canadian Myeloma Research Group
Phase 2 Withdrawn
NCT03785704 2020-01-22
Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer
Peking Union Medical College
Phase 2 Unknown
NCT04182594 2019-12-02
Cardiovascular Events in GnRH Agonist vs. Antagonist
Rabin Medical Center
Phase 2 Unknown
NCT01733953 2016-12-14
Statin Therapy in Young Adult Survivors of Childhood Cancer
University of Minnesota
Phase 2 Completed
NCT00006181 2014-01-07
PHLAME
Oregon Health and Science University
Phase 2 Completed